Nasdaq Denies Caring Brands' Continued Listing, Suspension Set for July 24
CABR filed a Corporate Governance and Compliance on light trading volume (0.3× avg).
Summary
Nasdaq has denied Caring Brands' continued listing, with trading suspension set for July 24 unless the company requests a hearing by July 22. The delisting stems from noncompliance with equity requirements — stockholders' equity below $2.5 million and failure to meet alternative standards. This follows a series of red flags: a May 10-Q showing worsening losses and negative equity, a massive S-1 registering 18.9 million shares for resale, and a recent $400K PIPE at deeply dilutive terms. The company intends to appeal, which would stay the suspension temporarily, but the denial confirms the exchange's view that the financial position is untenable. With a market cap around $12 million and a stock price of $1.30, the appeal is a last-ditch effort to avoid moving to the OTC market.
At the time of this announcement, CABR was trading at $1.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.8M. The 52-week trading range was $0.06 to $6.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.